The company focuses on managing diagnostic imaging centers, and it has slow and predicable revenue growth with decent margins. In my view, the Q2 FY24 results were strong as revenues inched up by 4.7% to $25.4 million while attributable net income soared by 68.4% to $3.8 million. The market capitalization of Fonar slumped by over 20% in the past month, and I think this creates a good buying opp...
FONAR Corporation's shares have declined 8.2% since I last wrote about it, while the S&P 500 gained 10.9%. The company's recent financial results show flatlined revenue and increased costs. Despite the weak performance, FONAR has a strong capital structure and the shares are objectively cheap, making it a potentially good investment. Patience is required in my view.
FONAR stock is trading well below book value and remains profitable which is key. Cash, liquidity and equity all continue to grow on the balance sheet.
I think the financial performance has been excellent over the past three quarters. I particularly like the renewed strength of the capital structure. At the same time, the shares are cheap by some measures, and not cheap by others. For that reason, I'm "nibbling" by buying 300 more shares.
MELVILLE, N.Y., March 09, 2021 (GLOBE NEWSWIRE) -- FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, will ring the Nasdaq Stock Market Closing Bell on March 9, 2021. Nasdaq and FONAR selected this day as it is 50 years since the discovery of MRI by Raymond V. Damadian, M.D., FONAR's founder and chairman, was published in the widely-read, peer-reviewed scientific journal Science on ...
Blue Tower Asset Management's recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 10.4% for the quarter, outperforming the S&P 500 Index which returned 8.9% in the same quarter. You should check out Blue Tower Asset Management's top 5 stock picks for investors to buy right now, which could be the biggest winners of this year.
Benjamin Graham, the father of value investing and author of "The Intelligent Investor," advised value investors to screen for stocks whose "Graham blended multiplier" stood below 22.5. Such stocks could be trading at a discount to their intrinsic value, enhancing the likelihood to come across value opportunities.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.